1. Cancer statistics, 1999, CA.;Landis;Cancer J. Clin.,1999
2. Focus on epithelial ovarian cancer;Ozols;Cancer Cell,2004
3. U. Wagner, S. Kohler, S. Reinartz, P. Giffels, J. Huober, K. Renke, H. Schlebusch, H.J. Biersack, V. Mobus, R. Kreienberg, T. Bauknecht, D. Krebs, D. Wallwiener, Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112–1115, 2001. Clin. Cancer Res. 7 (2001) 1154–1162.
4. Immunological treatment of ovarian cancer;Cannon;Curr. Opin. Obstet. Gynecol.,2004
5. The use of dendritic cells in cancer immunotherapy;Schuler;Curr. Opin. Immunol.,2003